Some Thoughts on the Reporting of Adverse Events in Phase II Cancer Clinical Trials-Reference-Cited by-同舟云学术

Some Thoughts on the Reporting of Adverse Events in Phase II Cancer Clinical Trials

Published:2006-08-20 Issue:24 Volume:24 Page:3821-3822
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Anderson Stewart J.¹

Affiliation:

1. National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.06.9856

Reference5 articles.

1. Adverse Event Reporting in Publications Compared With Sponsor Database for Cancer Clinical Trials

2. Dealing With a Deluge of Data: An Assessment of Adverse Event Data on North Central Cancer Treatment Group Trials

3. Early Detection of Toxicity and Adjustment of Ongoing Clinical Trials: The History and Performance of the North Central Cancer Treatment Group’s Real-Time Toxicity Monitoring Program

4. The Reliability of Medical Record Review for Estimating Adverse Event Rates

5. Mortality Associated With Irinotecan Plus Bolus Fluorouracil/Leucovorin: Summary Findings of an Independent Panel

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal toxicities from targeted therapies;Current Opinion in Supportive & Palliative Care;2015-06

2. Failure or success of search strategies to identify adverse effects of medical devices: a feasibility study using a systematic review;Systematic Reviews;2014-10-13

3. Failure or success of electronic search strategies to identify adverse effects data;Journal of the Medical Library Association : JMLA;2012-04

4. Notes toward a politics of personalization;Proceedings of the 2011 iConference;2011-02-08

5. Evaluating and Reporting Dysphagia in Trials of Chemoirradiation for Head-and-Neck Cancer;International Journal of Radiation Oncology*Biology*Physics;2010-07